Details of Host Protein-DME Interaction (HOSPPI)
General Information of Drug-Metabolizing Enzyme (DME ID: DME0147) | |||||
---|---|---|---|---|---|
DME Name | Cellular glutathione peroxidase (GPX1), Homo sapiens | DME Info | |||
UniProt ID | |||||
EC Number | EC: 1.11.1.9 (Click to Show/Hide the Complete EC Tree) | ||||
Lineage | Species: Homo sapiens (Click to Show/Hide the Complete Species Lineage) | ||||
Interactome |
Disease Specific Interactions between Host Protein and DME (HOSPPI) | |||||
---|---|---|---|---|---|
ICD Disease Classification Healthy | |||||
ICD-11: Healthy | Click to Show/Hide the Full List of HOSPPI: 1 HOSPPI | ||||
Histone modification | |||||
Histone deacetylases (HDACs) | Health | Repression | |||
Uniprot ID | |||||
Interaction Name | HDACs-GPX1 interaction | [1] | |||
Studied Cell Lines | Rat bone marrow cells | ||||
Description | Histone deacetylases (HDACs) are reported to deacetylate the GPX1 gene and thereby repress the transcriptional activity of the drug-metabolizing enzyme Cellular glutathione peroxidase. As a result, the interaction between HDACs and GPX1 can inhibit the drug-metabolizing process of Cellular glutathione peroxidase. | ||||
ICD Disease Classification 02 Neoplasms | |||||
ICD-11: 2A00 Brain cancer | Click to Show/Hide the Full List of HOSPPI: 1 HOSPPI | ||||
DNA methylation | |||||
DNA methyltransferase (DNMT) | Medulloblastoma | Moderate hypermethylation | |||
Interaction Name | DNMT-GPX1 interaction | ||||
The Methylation Level of Disease Section Compare with the Healthy Individual Tissue | Moderate hypermethylation p-value: 9.53E-25; delta-beta: 2.04E-01 | ||||
Description | DNA methyltransferase (DNMT) is reported to moderatly hyper-methylate the GPX1 gene, which leads to a moderatly decreased expression of the drug-metabolizing enzyme Cellular glutathione peroxidase. As a result, the interaction between DNMT and GPX1 can moderatly affect the drug-metabolizing process of Cellular glutathione peroxidase. | ||||
DME methylation in the diseased tissue of patients
DME methylation in the normal tissue of healthy individuals
|
|||||
Violin Diagram of DME Disease-specific Methylation Level | Click to View the Clearer Original Diagram | ||||
ICD-11: 2B30 Lymphoma | Click to Show/Hide the Full List of HOSPPI: 1 HOSPPI | ||||
DNA methylation | |||||
DNA methyltransferase (DNMT) | Lymphoma | Significant hypomethylation | |||
Interaction Name | DNMT-GPX1 interaction | ||||
The Methylation Level of Disease Section Compare with the Healthy Individual Tissue | Significant hypomethylation p-value: 7.87E-16; delta-beta: -4.76E-01 | ||||
Description | DNA methyltransferase (DNMT) is reported to significantly hypo-methylate the GPX1 gene, which leads to a significantly increased expression of the drug-metabolizing enzyme Cellular glutathione peroxidase. As a result, the interaction between DNMT and GPX1 can significantly affect the drug-metabolizing process of Cellular glutathione peroxidase. | ||||
DME methylation in the diseased tissue of patients
DME methylation in the normal tissue of healthy individuals
|
|||||
Violin Diagram of DME Disease-specific Methylation Level | Click to View the Clearer Original Diagram | ||||
ICD-11: 2C12 Liver cancer | Click to Show/Hide the Full List of HOSPPI: 1 HOSPPI | ||||
DNA methylation | |||||
DNA methyltransferase (DNMT) | Liver cancer | Significant hypomethylation | |||
Interaction Name | DNMT-GPX1 interaction | ||||
The Methylation Level of Disease Section Compare with the Healthy Individual Tissue | Significant hypomethylation p-value: 4.41E-11; delta-beta: -3.20E-01 | ||||
Description | DNA methyltransferase (DNMT) is reported to significantly hypo-methylate the GPX1 gene, which leads to a significantly increased expression of the drug-metabolizing enzyme Cellular glutathione peroxidase. As a result, the interaction between DNMT and GPX1 can significantly affect the drug-metabolizing process of Cellular glutathione peroxidase. | ||||
The Methylation Level of Disease Section Compare with the Adjacent Tissue | Moderate hypomethylation p-value: 2.22E-08; delta-beta: -2.99E-01 | ||||
Description | DNA methyltransferase (DNMT) is reported to moderatly hypo-methylate the GPX1 gene, which leads to a moderatly increased expression of the drug-metabolizing enzyme Cellular glutathione peroxidase. As a result, the interaction between DNMT and GPX1 can moderatly affect the drug-metabolizing process of Cellular glutathione peroxidase. | ||||
DME methylation in the diseased tissue of patients
DME methylation in the normal tissue adjacent to the diseased tissue of patients
DME methylation in the normal tissue of healthy individuals
DME methylation in tissue other than the diseased tissue of patients
|
|||||
Violin Diagram of DME Disease-specific Methylation Level | Click to View the Clearer Original Diagram | ||||
ICD-11: 2C25 Lung cancer | Click to Show/Hide the Full List of HOSPPI: 1 HOSPPI | ||||
DNA methylation | |||||
DNA methyltransferase (DNMT) | Lung cancer | Moderate hypomethylation | |||
Interaction Name | DNMT-GPX1 interaction | ||||
The Methylation Level of Disease Section Compare with the Other Disease Section | Moderate hypomethylation p-value: 1.75E-07; delta-beta: -2.15E-01 | ||||
Description | DNA methyltransferase (DNMT) is reported to moderatly hypo-methylate the GPX1 gene, which leads to a moderatly increased expression of the drug-metabolizing enzyme Cellular glutathione peroxidase. As a result, the interaction between DNMT and GPX1 can moderatly affect the drug-metabolizing process of Cellular glutathione peroxidase. | ||||
DME methylation in the diseased tissue of patients
DME methylation in the normal tissue of healthy individuals
DME methylation in tissue other than the diseased tissue of patients
|
|||||
Violin Diagram of DME Disease-specific Methylation Level | Click to View the Clearer Original Diagram | ||||
ICD-11: 2C30 Melanoma | Click to Show/Hide the Full List of HOSPPI: 1 HOSPPI | ||||
DNA methylation | |||||
DNA methyltransferase (DNMT) | Melanoma | Significant hypomethylation | |||
Interaction Name | DNMT-GPX1 interaction | ||||
The Methylation Level of Disease Section Compare with the Healthy Individual Tissue | Significant hypomethylation p-value: 1.71E-07; delta-beta: -4.12E-01 | ||||
Description | DNA methyltransferase (DNMT) is reported to significantly hypo-methylate the GPX1 gene, which leads to a significantly increased expression of the drug-metabolizing enzyme Cellular glutathione peroxidase. As a result, the interaction between DNMT and GPX1 can significantly affect the drug-metabolizing process of Cellular glutathione peroxidase. | ||||
DME methylation in the diseased tissue of patients
DME methylation in the normal tissue of healthy individuals
|
|||||
Violin Diagram of DME Disease-specific Methylation Level | Click to View the Clearer Original Diagram | ||||
ICD-11: 2C60 Breast cancer | Click to Show/Hide the Full List of HOSPPI: 1 HOSPPI | ||||
Transcription-factor regulation | |||||
TF factor AP-2 gamma (TFAP2C) | Breast cancer | Activation | |||
Uniprot ID | |||||
Interaction Name | TFAP2C-GPX1 interaction | [2] | |||
Studied Cell Lines | MCF-7, BT-474, MDA-MB-453 and SKBR-3 cell lines | ||||
Ensembl ID | |||||
Description | TF factor AP-2 gamma (TFAP2C) is reported to activate the transcription of GPX1 gene, which leads to an increased expression of the drug-metabolizing enzyme Cellular glutathione peroxidase. As a result, the interaction between TFAP2C and GPX1 can activate the drug-metabolizing process of Cellular glutathione peroxidase. | ||||
ICD-11: 2C73 Ovarian cancer | Click to Show/Hide the Full List of HOSPPI: 1 HOSPPI | ||||
DNA methylation | |||||
DNA methyltransferase (DNMT) | Ovarian cancer | Significant hypomethylation | |||
Interaction Name | DNMT-GPX1 interaction | ||||
The Methylation Level of Disease Section Compare with the Healthy Individual Tissue | Significant hypomethylation p-value: 3.20E-04; delta-beta: -3.51E-01 | ||||
Description | DNA methyltransferase (DNMT) is reported to significantly hypo-methylate the GPX1 gene, which leads to a significantly increased expression of the drug-metabolizing enzyme Cellular glutathione peroxidase. As a result, the interaction between DNMT and GPX1 can significantly affect the drug-metabolizing process of Cellular glutathione peroxidase. | ||||
DME methylation in the diseased tissue of patients
DME methylation in the normal tissue of healthy individuals
|
|||||
Violin Diagram of DME Disease-specific Methylation Level | Click to View the Clearer Original Diagram | ||||
ICD-11: 2F7C Connective tissue cancer | Click to Show/Hide the Full List of HOSPPI: 1 HOSPPI | ||||
DNA methylation | |||||
DNA methyltransferase (DNMT) | Hemangioblastoma | Significant hypomethylation | |||
Interaction Name | DNMT-GPX1 interaction | ||||
The Methylation Level of Disease Section Compare with the Healthy Individual Tissue | Significant hypomethylation p-value: 2.64E-12; delta-beta: -4.36E-01 | ||||
Description | DNA methyltransferase (DNMT) is reported to significantly hypo-methylate the GPX1 gene, which leads to a significantly increased expression of the drug-metabolizing enzyme Cellular glutathione peroxidase. As a result, the interaction between DNMT and GPX1 can significantly affect the drug-metabolizing process of Cellular glutathione peroxidase. | ||||
DME methylation in the diseased tissue of patients
DME methylation in the normal tissue of healthy individuals
|
|||||
Violin Diagram of DME Disease-specific Methylation Level | Click to View the Clearer Original Diagram | ||||
ICD-11: 2F9A Endocrine gland cancer | Click to Show/Hide the Full List of HOSPPI: 1 HOSPPI | ||||
DNA methylation | |||||
DNA methyltransferase (DNMT) | Craniopharyngioma | Significant hypomethylation | |||
Interaction Name | DNMT-GPX1 interaction | ||||
The Methylation Level of Disease Section Compare with the Healthy Individual Tissue | Significant hypomethylation p-value: 6.03E-18; delta-beta: -3.50E-01 | ||||
Description | DNA methyltransferase (DNMT) is reported to significantly hypo-methylate the GPX1 gene, which leads to a significantly increased expression of the drug-metabolizing enzyme Cellular glutathione peroxidase. As a result, the interaction between DNMT and GPX1 can significantly affect the drug-metabolizing process of Cellular glutathione peroxidase. | ||||
DME methylation in the diseased tissue of patients
DME methylation in the normal tissue of healthy individuals
|
|||||
Violin Diagram of DME Disease-specific Methylation Level | Click to View the Clearer Original Diagram | ||||
ICD Disease Classification 05 Endocrine/nutritional/metabolic diseases | |||||
ICD-11: 5B81 Obesity | Click to Show/Hide the Full List of HOSPPI: 1 HOSPPI | ||||
DNA methylation | |||||
DNA methyltransferase (DNMT) | Obesity | Moderate hypermethylation | |||
Interaction Name | DNMT-GPX1 interaction | ||||
The Methylation Level of Disease Section Compare with the Healthy Individual Tissue | Moderate hypermethylation p-value: 4.14E-02; delta-beta: 2.14E-01 | ||||
Description | DNA methyltransferase (DNMT) is reported to moderatly hyper-methylate the GPX1 gene, which leads to a moderatly decreased expression of the drug-metabolizing enzyme Cellular glutathione peroxidase. As a result, the interaction between DNMT and GPX1 can moderatly affect the drug-metabolizing process of Cellular glutathione peroxidase. | ||||
DME methylation in the diseased tissue of patients
DME methylation in the normal tissue of healthy individuals
|
|||||
Violin Diagram of DME Disease-specific Methylation Level | Click to View the Clearer Original Diagram | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.